Search

Displaying results 5931 - 5940 of 8196 in total
  1. Drug

    Lingdolinurad

    go.drugbank.com/drugs/DB21659
    Experimental

    Lingdolinurad has a monoisotopic molecular weight of 369.01 Da.

  2. Drug

    Relicpixant

    go.drugbank.com/drugs/DB21671
    Experimental

    Relicpixant has a monoisotopic molecular weight of 500.07 Da.

  3. Drug

    Muvadenant

    go.drugbank.com/drugs/DB21684
    Experimental

    Muvadenant has a monoisotopic molecular weight of 430.17 Da.

  4. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    Darbinurad has a monoisotopic molecular weight of 324.09 Da.

  5. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    Remlifanserin has a monoisotopic molecular weight of 429.22 Da.

  6. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    Envudeucitinib has a monoisotopic molecular weight of 426.23 Da.

  7. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    Zemprocitinib has a monoisotopic molecular weight of 345.13 Da.

  8. Drug

    Salix alba bark volatile oil

    go.drugbank.com/drugs/DB14354
    Investigational

    It is not an approved drug.

  9. Drug

    Mitumomab

    go.drugbank.com/drugs/DB06462
    Experimental

    Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

  10. Drug

    Fontolizumab

    go.drugbank.com/drugs/DB05111
    Investigational

    Fontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.